Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 20, 1997

View Archived Issues

Andrx seeks patent coverage for new drug delivery system

Patent coverage obtained for SomatoKine in osteoporosis, tissue repair

Positive preclinical results obtained with Avigen's antiparkinsonian gene therapy

Pseudopeptide derivatives of OGP and OGP(10-14) disclosed by Yissum

Pharmacological characterization of CCD-3693, an orally available neuroactive steroid

Thalidomide proves effective in HIV-associated proctitis

Effects of rPAF-AH in opossums with severe pancreatitis

Safety and biochemical effects of DFMO support phase III trials for colon cancer prevention

Insulin therapy found useful in patients with type II diabetes

United Biomedical and California lab to collaborate on novel HIV therapeutic

Preliminary phase III data presented on celecoxib at arthritis symposium

Enbrel phase III and long-term safety data presented at rheumatology meeting

Update on Prizm's novel Directin-based product pipeline

Alza: Q3 1997 highlights

New ACAT inhibitor from Pierre Fabre

GL-701 shows significant steroid-sparing effects in women with active SLE

Synvisc introduced in U.S.

Novartis' NK1 antagonist in clinical studies for pain

Matritech: Q3 1997 highlights

Beclometasone CFC-free MDI for chronic bronchial asthma approved

FDA advisory committee recommends approval of Prandin

Life Medical Sciences: Q2 and nine-month 1997 highlights

Nortran and Bridge Pharma to develop dermal anesthetics

FDA advisory committee to review rotavirus vaccine

Extensive preclinical results described for new NK2 antagonist

HMR and MediGene collaborate on cancer gene therapies

Phase II results with T-cell receptor peptides in RA promising

Phase II begins for psoriasis vaccine

New NK3/NK4 antagonist in the pipeline at SKB

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...